Suspension of trading
Sector Chart Catalyst Pharmaceuticals, Inc. Deutsche Boerse AG
Stocks
CN2
US14888U1016
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.30 EUR | +2.63% |
|
+0.74% | +35.01% |
| 07-16 | Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals | MT |
| 07-16 | Deals of the day-Mergers and acquisitions | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 3.85B | - | - | |||
| 68.85B | |||||
| 52.13B | |||||
| 43.46B | |||||
| 41.24B | - | ||||
| 30.41B |
Select your edition
All financial news and data tailored to specific country editions
